Abreva

Abreva is an over-the-counter cold sore treatment brand. Its principal product is a topical treatment containing 10% docosanol, intended for cold sores on the lips and face associated with herpes simplex virus. It is generally positioned for use at the first sign of symptoms to help shorten healing time. The brand was formerly part of GlaxoSmithKline’s consumer healthcare business and is now associated with Haleon following the formation of that company from the consumer healthcare businesses of GSK and Pfizer. Reliable public information is insufficient to establish an independent founding date or a broader product portfolio.

Abreva’s core offering is an over-the-counter topical cold sore treatment containing 10% docosanol. The active ingredient is used in a topical product designed for consumer treatment of cold sores in a home setting. Public information has commonly associated the brand with GlaxoSmithKline’s consumer healthcare business. In 2022, GSK’s consumer healthcare business combined with Pfizer’s consumer healthcare business to form Haleon, which began operating as an independent consumer healthcare company; Abreva became part of Haleon’s brand portfolio. Available material is insufficient to confirm the brand’s founding year, founder, complete international market coverage, or a more extensive historical chronology.

1. 2022Transition to Haleon brand portfolio

   Following the demerger of GSK's consumer healthcare business and its merger with Pfizer's consumer healthcare business to form Haleon, Abreva became a consumer healthcare brand under Haleon.

   Source

Over-the-counter topical treatment brand for cold sores

• Abreva Cold Sore TreatmentOver-the-counter topical medication

  Abreva’s core topical over-the-counter treatment for cold sores on the lips and face. Its principal active ingredient is 10% docosanol, and the product is positioned for use at the early signs of a cold sore.

• 2022Haleon becomes an independent consumer healthcare company

  Haleon 从葛兰素史克分拆并上市，承接包括 Abreva 在内的相关消费者健康品牌。

  M&AOther
  Source

1. Haleon starts trading as a new world-leading consumer healthcare company
2. Abreva official website